RecruitingRecruiting
Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
NCT06089161 · University of Miami
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
About this study
The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).
Eligibility criteria
Inclusion Criteria:
* Self-reported race/ethnicity as African American, African, Caribbean or black
* Ages 60-85 years
* accessible by phone
* OSA diagnosis
* consent, including permission to release medical data
Exclusion Criteria:
* progressive illnesses in which disability or death is expected within 1 year
* impaired cognitive/ functional ability precluding participation
* intention to move within the year
* and a family member currently enrolled.
Study design
Enrollment target: 330 participants
Allocation: randomized
Masking: single
Age groups: adult, older_adult
Timeline
Starts: 2024-03-19
Estimated completion: 2028-05-31
Last updated: 2025-05-08
Interventions
Other: Standard of CareBehavioral: Personalized OSA Treatment
Primary outcomes
- • Proportion of participants adherence to OSA treatment (Up to 6 months)
Sponsor
University of Miami · other
With: National Institute on Aging (NIA)
Contacts & investigators
ContactGirardin Jean-Louis, PhD · contact · girardin.jean-louis@miami.edu · 3052430776
InvestigatorGirardin Jean-Louis, PhD · principal_investigator, University of Miami
All locations (1)
University of MiamiRecruiting
Miami, Florida, United States